OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The pathogenetic role of Th17 immune response in atopic dermatitis	53
What molecular allergy teaches us about genetics and epidemiology of allergies	27
The use of environmental exposure chambers in studies related to ocular surface effects	23
Economic burden of drug-induced anaphylaxis: what can we do better?	22
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	21
Consequences of severe asthma exacerbations	19
Liver disease in primary antibody deficiencies	19
Is immunotherapy safe for treatment of severe asthma	19
Anaphylaxis due to antiallergic and antiasthmatic biologics	18
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	18
Dietary strategies for the prevention of asthma in children	18
Pulmonary function testing for the diagnosis of asthma in preschool children	17
Cow's milk allergy	17
E-cigarettes and asthma in adolescents	16
Update on occupational allergy, including asthma, to soluble platinum salts	15
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	15
Atopic manifestations of inborn errors of immunity	14
Innate and adaptive immunity in allergic airway disease	14
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	13
Mast cell conditions and drug allergy: when to suspect and how to manage	13
Real-world evidence of allergen immunotherapy	13
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	12
Transition of care in inborn errors of immunity	12
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	12
Ocular involvement in allergic drug reactions	12

Editorial introductions	12
New approaches in childhood asthma treatment	12
Editorial introductions	12
Perioperative anaphylaxis: when the allergological work-up goes negative	12
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	11
Nanoparticles in allergen immunotherapy	11
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	11
Drug allergy desensitization is not a unique recipe	11
Biological therapies, asthma and coronavirus disease 2019	11
Editorial introductions	10
Editorial introductions	10
Updates in diagnosis and management of paediatric mastocytosis	10
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	10
An immunologist's perspective on anti-COVID-19 vaccines	10
Editorial introductions	10
A review of food allergy-related costs with consideration to clinical and demographic factors	9
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	9
Evaluating the glucagon-like peptide-1 receptor in managing asthma	9
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	8
Management and treatment of perioperative hypersensitivity	8
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	8
Health disparities in allergic diseases	8
Food-labeling issues for severe food-allergic consumers	8
Occupational causes of chronic obstructive pulmonary disease: an update	8
Updates in school-based asthma management	8
Atopic dermatitis endotypes: knowledge for personalized medicine	8
Editorial introductions	7
Role of the ocular surface microbiome in allergic eye diseases	7
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	7
Precision allergy molecular diagnosis applications in food allergy	7
The complexity in DNA methylation analysis of allergic diseases	7
Food allergy: new therapeutic options open deeper questions	7
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	7
Strengthening the case for intralymphatic immunotherapy	7
Current strategies for phenotyping and managing asthma in preschool children	7
Biomarkers in the diagnosis of mast cell activation	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	7
Interstitial lung diseases in inborn errors of immunity	6
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	6
Occupational respiratory allergy to reactive dyes	6
Immunobiologicals and ocular surface disease	6
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	6
Adverse effects of anti-cancer biologics on the ocular surface	6
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
New causes of occupational allergic contact dermatitis	6
Precision medicine to personalize medicine in allergic airway disease	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
Giant cell arteritis and innovative treatments	6

Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
The role of macrolides in chronic rhinosinusitis and nasal polyps	6
Editorial introductions	5
Omalizumab is the Columbus egg for food allergies	5
New evidence in food allergies treatment	5
The development of the DEFASE project	5
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	5
The risk of anaphylaxis on holidays	5
Endotypes of occupational asthma	5
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	5
New insights in mite immunotherapy – sublingual tablets	5
Editorial introductions	5
MicroCrystalline Tyrosine-adsorbed immunotherapy	5
Moderate asthma: burden, mechanisms and therapeutic perspectives	4
Editorial: Pharmacotherapy and evidence based medicine	4
Editorial introductions	4
Perioperative anaphylaxis: updates on pathophysiology	4
Clinical outcomes of AIT in the elderly population	4
New insights into the mechanisms of aspirin-exacerbated respiratory disease	4
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	4
Ocular surface disorders: office procedures for the allergist/clinical immunologist	4
Neurostimulation for dry eye disease	4
How E-cigarettes and vaping can affect asthma in children and adolescents	4
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	4
Genetic landscape of atopic dermatitis	4
Diagnosis, management and therapeutic options for eosinophilic esophagitis	4
Editorial introductions	4
Role of biologics in severe food allergy	4
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	4
An update on patient reported outcomes in type 2 inflammation airway disease	4
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	4
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	4
Recent advances in the diagnosis and management of tree nut and seed allergy	4
Editorial introductions	4
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	4
Integrative therapeutics for ocular surface disorders	3
Management of food allergy based on oral food challenge	3
Anaphylaxis in elderly people	3
Editorial introductions	3
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	3
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	3
Inborn errors of immunity underlying defective T-cell memory	3
Chronic urticaria: not only after COVID-19 vaccination	3
Applying the new guidelines to asthma management in children	3
Predicting the course of asthma from childhood until early adulthood	3
Corneal complications of rheumatoid arthritis	3
Biologics to treat anaphylaxis	3
Anaphylaxis: glimpse into the future, attention to the present	3
Editorial introductions	3
Perspectives in precautionary allergen labelling of prepackaged foods after the FAO/WHO consultation	3
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	3
The evolution of cyclosporine treatments for treatment of ocular surface diseases	3
Editorial introductions	3
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	3
Biologics and severe asthma in children	3
Biologicals in IgE-mediated food allergy	3
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	3
Long-term outcome of occupational asthma with different etiology	3
Advances in gene therapy for inborn errors of immunity	3
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management	3